Skip to main content

Table 1 Baseline demographic and clinical characteristics, ITT population*

From: First-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressure

 

Baseline IOP

Characteristic

20 to <24 mmHg

N = 252

≥ 24 mmHg

N = 320

Age, years

  

   Mean ± SD

59.9 ± 12.2

59.1 ± 11.8

Gender, male

117 (46.4)

174 (54.4)

Diagnosis

  

   Ocular hypertension

150 (59.5)

161 (50.3)

   Open-angle glaucoma

102 (40.5)

159 (49.7)

Open-angle glaucoma grade

  

   Mild

77 (75.5)

96 (60.4)

   Moderate

21 (20.6)

43 (27.0)

   Severe

4 (3.9)

20 (12.6)

Intraocular pressure

  

   Mean (SD)

22.2 ± 0.9

26.7 ± 2.8

Family history of ocular

  

   hypertension or glaucoma

85 (33.7)

73 (22.8)

Body mass index

  

   Mean (SD)

25.0 ± 3.9

25.1 ± 3.9

Comorbidities

  

   Diabetes

17 (8.7)

33 (13.3)

   Hypertension

69 (35.2)

77 (30.8)

   Sleep disorders

39 (19.8)

34 (13.7)

Myopia

78 (31.0)

95 (29.7)

   <-12 diopters

1 (1.3)

3 (3.2)

   Between -6 and -12 diopters

9 (11.5)

13 (13.7)

   >-6 diopters

68 (87.2)

79 (83.2)

Tobacco use within prior year§

55 (28.1)

83 (33.3)

  1. *n (%) unless otherwise noted.
  2. Percentages based on number of subjects with open-angle glaucoma.
  3. Percentages based on number of subjects reporting presence/absence of comorbidities.
  4. §Percentages based on numbers of subjects reporting use/no use of tobacco within prior year.
  5. ITT = intent to treat; SD = standard deviation.